Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 14 results.
User Information
Export Records
  1. 1.   The G-Protein Coupled Formyl Peptide Receptors and Their Role in the Progression of Digestive Tract Cancer
  2. Tian, Cuimeng; Chen,Keqiang; Gong, Wanghua; Yoshimura, Teizo; Huang, Jiaqiang; Wang,Jiming
  3. Technology in cancer research & treatment. 2020, Jan-Dec; 19: pii: 1533033820973280.
  1. 2.   Chemotactic Ligands that Activate G-Protein-Coupled Formylpeptide Receptors
  2. Krepel,Stacey; Wang,Jiming
  3. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2019, Jul; 20(14):
  1. 3.   Copper regulates the interactions of antimicrobial piscidin peptides from fish mast cells with formyl peptide receptors and heparin
  2. Kim, So Young; Zhang, Fuming; Gong, Wang; Chen, Keqiang; Xia, Kai; Liu, Fei; Gross, Richard A; Wang, Jiming; Linhardt, Robert J; Cotten, Myriam L
  3. Journal of Biological Chemistry. 2018, Oct 5; 293(40): 15381-15396.
  1. 4.   Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation
  2. Huang, J.; Chen, K. Q.; Huang, J. Q.; Gong, W. H.; Dunlop, N. M.; Howard, O.; Bian, X. W.; Gao, Y. Q.; Wang, J. M.
  3. Carcinogenesis. 2009 30(2): 348-355.
  1. 5.   Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR
  2. Yao, X. H.; Ping, Y. F.; Chen, J. H.; Xu, C. P.; Chen, D. L.; Zhang, R.; Wang, J. M.; Bian, X. W.
  3. Journal of Pathology. 2008 215(4): 369-376.
  1. 6.   A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors
  2. Chen, J. H.; Yao, X. H.; Gong, W.; Hu, J.; Zhou, X. D.; Chen, K.; Liu, H.; Ping, Y. F.; Wang, J. M.; Bian, X. W.
  3. Journal of Neuro-Oncology. 2007, Sep; 84(3): 223-231.
  1. 7.   Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival
  2. Bian, X. W.; Yang, S. X.; Chen, L. H.; Ping, Y. F.; Zhou, X. D.; Wang, Q. L.; Jiang, X. F.; Gong, W. H.; Xiao, H. L.; Du, L. L.; Chen, Z. Q.; Zhao, W.; Shi, L. Q.; Wang, J. M.
  3. Neurosurgery. 2007, Sep; 61(3): 570-578.
  1. 8.   Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells
  2. Huang, J.; Hu, J. Y.; Bian, X. W.; Chen, K. Q.; Gong, W. H.; Dunlop, N. M.; Howard, O. M. Z.; Wang, J. M.
  3. Cancer Research. 2007, Jun; 67(12): 5906-5913.
  1. 9.   Silencing the formylpeptide receptor FPR by short-interfering RNA
  2. Le, Y. Y.; Iribarren, P.; Zhou, Y.; Gong, W. H.; Hu, J. Y.; Zhang, X.; Wang, J. M.
  3. Molecular Pharmacology. 2004, OCT; 66(4): 1022-1028.
  1. 10.   Humanin, a newly identified neuroprotective factor, uses the g protein-coupled formylpeptide receptor-like-1 as a functional receptor
  2. Ying, G. G.; Iribarren, P.; Zhou, Y.; Gong, W. H.; Zhang, N.; Yu, Z. X.; Le, Y.; Cui, Y.; Wang, J. M.
  3. Journal of Immunology. 2004 172(11): 7078-7085.
  1. 11.   Receptors for chemotactic formyl peptides as pharmacological targets
  2. Le, Y. Y.; Yang, Y. M.; Cui, Y. H.; Yazawa, H.; Gong, W. H.; Qiu, C. P.; Wang, J. M.
  3. International Immunopharmacology. 2002 2(1): 1-13.
  1. 12.   Pleiotropic roles of formyl peptide receptors
  2. Le, Y. Y.; Oppenheim, J. J.; Wang, J. M.
  3. Cytokine & Growth Factor Reviews. 2001 12(1): 91-105.
  1. 13.   Desensitization of chemokine receptor CCR5 in dendritic cells at the early stage of differentiation by activation of formyl peptide receptors
  2. Le, Y. Y.; Wetzel, M. A.; Shen, W. P.; Gong, W. H.; Rogers, T. J.; Henderson, E. E.; Wang, J. M.
  3. Clinical Immunology. 2001 99(3): 365-372.
  1. 14.   Expression of functional formyl peptide receptors by human astrocytoma cell lines
  2. Le, Y. Y.; Hu, J. Y.; Gong, W. H.; Shen, W. P.; Li, B. Q.; Dunlop, N. M.; Halverson, D. O.; Blair, D. G.; Wang, J. M.
  3. Journal of Neuroimmunology. 2000 111(1-2): 102-108.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel